STELARA 90 mg solution for injection in pre-filled syringe

STELARA 90 mg solution for injection in pre-filled syringe is an essential therapy for individuals suffering from moderate to severe psoriasis and psoriatic arthritis. This biologic medication offers a convenient and effective treatment option, allowing patients to manage their symptoms with fewer injections per year.

Understanding how STELARA works and its recommended dosage is crucial for effective treatment. In this article, we will explore various aspects of STELARA, including its usage, administration, and potential side effects.

What Is STELARA® (Ustekinumab) And How Does It Work?

STELARA® is a monoclonal antibody that targets specific proteins in the immune system. By inhibiting the action of interleukin-12 and interleukin-23, STELARA helps to regulate immune responses that lead to inflammation. This can significantly improve symptoms for those with psoriatic arthritis and other related conditions.

The biologic is administered by subcutaneous injection, making it easier for patients to manage their treatment at home. STELARA 90 mg solution for injection in pre-filled syringe facilitates this process with user-friendly design, allowing for proper dosing without requiring excessive training.

Patients using STELARA may notice a reduction in joint pain and skin lesions over time. The controlled action of this medication can lead to a more stable and manageable condition for those with chronic inflammatory diseases.

What Are The Indications And Usage Of STELARA®?

STELARA is primarily indicated for the treatment of several conditions:

  • Moderate to severe plaque psoriasis
  • Psoriatic arthritis
  • Crohn’s disease
  • Ulcerative colitis

This medication is approved for use in patients aged 6 years and older, which includes both pediatric and adult populations. The flexibility in its indications makes STELARA a versatile choice for healthcare providers looking to offer comprehensive treatment options to their patients.

It is essential to ensure that STELARA is used under the supervision of a healthcare professional to monitor efficacy and manage any potential side effects. Regular assessments are crucial to adapt the treatment plan as necessary based on patient response.

What Is The Recommended Dosage For Psoriatic Arthritis?

The recommended dosage of STELARA for psoriatic arthritis typically begins with an initial dose of 45 mg, followed by maintenance doses administered every 12 weeks. However, for patients weighing over 220 lbs, the initial dosage is increased to 90 mg.

The dosing schedule is structured to minimize the number of injections required annually, making treatment less burdensome. Following the initial doses, patients will generally receive only four injections per year, enhancing adherence to treatment.

This simplified dosing regimen not only improves patient compliance but also allows for better management of the condition. Healthcare providers should tailor the dosage to the individual patient’s needs, ensuring optimal therapeutic outcomes.

How Is STELARA® Administered?

STELARA is administered via subcutaneous injection, which can be performed in a clinical setting or at home. How to give STELARA injection is a crucial aspect that patients should learn during their treatment plan initiation.

Before administering STELARA, patients should follow these guidelines:

  1. Prepare the injection site by cleaning the skin with an alcohol swab.
  2. Remove the pre-filled syringe from the refrigerator and let it reach room temperature before use.
  3. Insert the needle into the skin at a 90-degree angle and inject the medication slowly.
  4. Dispose of the syringe properly after use.

Training from a healthcare professional can enhance confidence in self-administration. It is vital to follow the proper techniques to ensure effective delivery of the medication.

What Are The Contraindications And Warnings For STELARA®?

While STELARA is effective for many patients, it is not suitable for everyone. Certain contraindications and warnings must be considered:

  • Known hypersensitivity to ustekinumab or any component of the formulation
  • Severe infections, as STELARA may increase the risk of serious infections
  • Patients with a history of tuberculosis should be evaluated prior to treatment

Proper screening and assessment are essential before initiating therapy. Patients should inform their healthcare providers about their medical history and any other medications they are currently taking to prevent adverse interactions.

Furthermore, regular monitoring for signs of infection or other serious reactions is crucial during treatment. Prompt reporting of any unusual symptoms can aid in the quick management of potential issues.

What Are The Adverse Reactions Associated With STELARA®?

Like any medication, STELARA has potential side effects. Some common adverse reactions include:

  • Injection site reactions (pain, redness, swelling)
  • Headache
  • Fatigue
  • Infections (such as upper respiratory infections)

Patients should be aware of these potential side effects and discuss them with their healthcare provider. Monitoring for adverse reactions is part of ensuring safe and effective treatment.

In rare cases, serious infections or hypersensitivity reactions may occur, necessitating immediate medical attention. Awareness and education about potential reactions can empower patients to seek help when needed.

Frequently Asked Questions About STELARA®

Questions related to STELARA administration and usage

How do you use a STELARA prefilled syringe?

Using a STELARA pre-filled syringe involves a few straightforward steps. First, ensure you have received proper training from a healthcare provider on how to administer the injection. The syringe should be kept in the refrigerator until it’s time to use it.

Before injection, let it warm to room temperature to minimize discomfort. Clean the injection site with an alcohol wipe, then pinch the skin and inject the medication at a 90-degree angle. After injecting, dispose of the syringe in a proper sharps container.

Does the STELARA 90 mg prefilled syringe contain latex?

No, the STELARA 90 mg prefilled syringe does not contain latex. This is an important consideration for patients with latex allergies, ensuring that they can safely use this medication without risk of an allergic reaction.

What is STELARA 90 mg ml PFS?

STELARA 90 mg ml PFS refers to the pre-filled syringe that contains 90 mg of ustekinumab in a single-use format. This convenient delivery system allows for easier administration, helping patients adhere to their prescribed dosing schedule without the need for additional reconstitution or preparation.

How much does 90 mg of STELARA cost?

The cost of STELARA can vary based on several factors, including insurance coverage and pharmacy pricing. Patients should consult their healthcare provider or pharmacist for specific pricing and potential financial assistance options that may be available to help manage costs.

Through comprehensive understanding and adherence to guidance regarding STELARA, patients can effectively manage their psoriatic arthritis or other related conditions. The convenience of the STELARA 90 mg solution for injection in pre-filled syringe makes it an invaluable option for many individuals striving for improved health.

Leave a Comment